Table 4 Postoperative outcome

Time to resume, mean ± SD, d

 PLOS

11.33 ± 2.54

13.49 ± 3.85

 < 0.001

 Off-bed activities

2.29 ± 0.71

2.83 ± 0.92

0.001

 Intake

1.93 ± 0.71

2.63 ± 0.67

 < 0.001

 Bowel movement

2.38 ± 0.58

2.90 ± 0.79

 < 0.001

POD1-WBC, mean ± SD, 10^9

9.75 ± 1.21

12.52 ± 1.72

 < 0.001

POD3-WBC, mean ± SD, 10^9

7.43 ± 1.18

10.33 ± 1.21

 < 0.001

Morbidity, n (%)

6(14.3)

31(36.9)

0.009

Hemorrhage, n (%)

1(2.4)

3(3.6)

1.000

Bileleakage, B class, n (%)

1(2.4)

8(9.5)

0.270

Abdominal abscess,n (%)

3(7.1)

11(13.1)

0.383

Liver failure, n (%)

1(2.4)

2(2.4)

1.000

Septic shock, n (%)

1(2.4)

4(4.8)

0.664

Wound infection, n (%)

1(2.4)

3(3.6)

1.000

Ileus, n (%)

2(4.8)

5(6.0)

1.000

Renal insufficiency, n (%)

1(2.4)

7(8.3)

0.267

Arrhythmia, n (%)

0(0)

3(3.6)

0.550

Delirium, n (%)

1(2.4)

11(13.1)

0.046

Pulmonary infection, n (%)

2(4.8)

9(10.7)

0.334

Death, n (%)

0(0)

2(2.4)

0.552

Reoperation, n (%)

0(0)

0(0)

1.000

Readmission, n (%)

1(2.4)

2(2.4)

1.000

Clavien-Dindo, n (%)

0.206

 I

1(2.4)

10(11.9)

 II

1(2.4)

5(6.0)

 III

3(7.1)

9(10.7)

 IV

1(2.4)

5(6.0)

 V

0(0)

2(2.4)

Lymphadenectasis in initial monitoring, n (%)

5(11.9)

21(25.0)

0.066